Tecan to present at J.P. Morgan Healthcare Conference
05 Enero 2017 - 4:45AM
Tecan Group AG / Tecan to present at J.P. Morgan Healthcare
Conference . Processed and transmitted by Nasdaq Corporate
Solutions. The issuer is solely responsible for the content of this
announcement.
Männedorf, Switzerland, January
5, 2017 - The Tecan Group (SIX Swiss Exchange: TECN) today
announced that it will present at J.P. Morgan Healthcare Conference
on January 11, 2017.
The investor presentation by David Martyr, CEO of
Tecan, will begin at 5:00 pm PST (2:00 am CET on January 12, 2017)
and will be webcast live. The webcast may be accessed under the
"Investor Relations" tab of Tecan's website www.tecan.com.
A replay of the webcast will be available after
the presentation and will remain available for 90 days.
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory
instruments and solutions in biopharmaceuticals, forensics and
clinical diagnostics. The company specializes in the development,
production and distribution of automated workflow solutions for
laboratories in the life sciences sector. Its clients include
pharmaceutical and biotechnology companies, university research
departments, and forensic and diagnostic laboratories. As an
original equipment manufacturer (OEM), Tecan is also a leader in
developing and manufacturing OEM instruments and components that
are then distributed by partner companies. Founded in Switzerland
in 1980, the company has manufacturing, research and development
sites in both Europe and North America and maintains a sales and
service network in 52 countries. In 2015, Tecan generated sales of
CHF 440 million (USD 459 million;
EUR 411 million). Registered shares of Tecan Group are
traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).
For further information:
Tecan Group
Martin Braendle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
Press Release
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Tecan Group AG via Globenewswire
--- End of Message ---
Tecan Group AG
Seestrasse 103 Maennedorf Switzerland
ISIN: CH0012100191;